EP3668854
NOVEL COMPOUNDS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.8.2018EP published:
12.1.2022EP application number:
18752499.6
EPO information:
European Patent Register
Max expiry date:
14.8.2038
Title in English:
NOVEL COMPOUNDSLanguage of the patent:
English
Timeline
Today
15.8.2018EP application
12.1.2022EP Publication
Owner
Name:
GlaxoSmithKline Intellectual Property Development LimitedAddress:
980 Great West Road, Brentford, Middlesex TW8 9GS, GB
Name:
Bioversys AGAddress:
Hochbergerstrasse 60c, 4057 Basel, CH
Inventor
Name:
PORRAS DE FRANCISCO, EstherAddress:
28760 Madrid, ES
Name:
REMUIÑAN-BLANCO, Modesto JesúsAddress:
28760 Madrid, ES
Name:
BOUROTTE, MarilyneAddress:
59840 Perenchies, FR
Name:
DEPREZ, BenoitAddress:
59000 Lille, FR
Name:
DEQUIREZ, GeoffroyAddress:
59160 Lomme, FR
Name:
WILLAND, NicolasAddress:
59000 Lille, FR
Priority
Number:
17382571Date:
16.8.2017Country:
EP
Classification
Categories:
C07D 401/04, C07D 405/04, C07D 205/04, A61K 31/397, A61P 31/06